Cargando…
Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)
BACKGROUND: Although high vaccine effectiveness of messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines has been reported in studies in several countries, data are limited from Asian countries, especially against the Delta (B.1.617.2) variant. METHODS: We conducted a multicenter test-ne...
Autores principales: | Maeda, Haruka, Saito, Nobuo, Igarashi, Ataru, Ishida, Masayuki, Suami, Kazuya, Yagiuchi, Ai, Kimura, Yuya, Komino, Masaru, Arai, Hiromi, Morikawa, Toru, Motohashi, Iori, Miyazawa, Rei, Moriyama, Tetsu, Kamura, Hiroshi, Terada, Mayumi, Kuwamitsu, Osamu, Hayakawa, Tomoichiro, Sando, Eiichiro, Ohara, Yasuji, Teshigahara, Osamu, Suzuki, Motoi, Morimoto, Konosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047210/ https://www.ncbi.nlm.nih.gov/pubmed/35438137 http://dx.doi.org/10.1093/cid/ciac292 |
Ejemplares similares
-
Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021) -
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021) -
Skin Adverse Reactions to Novel Messenger RNA Coronavirus Vaccination: A Case Series
por: Peigottu, Maria Francesca, et al.
Publicado: (2021) -
Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022) -
Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)